MoReLife – real-life data support the potential of momelotinib as a safe and effective treatment option for cytopenic myelofibrosis patients von Jilg, Stefanie, Schwaab, Juliana, Sockel, Katja, Crodel, Carl C., Brueckl, Valeska, Stegelmann, Frank, Jentzsch, Madlen, Sasca, Daniel, Moyses, Margarete, Fuhrmann, Stephan, Gundel, Daniel, Caduc, Madlen, Teichmann, Lino L., Heidel, Florian, Al-Ali, Haifa K., Petrides, Petro E.

Volltext